Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1

Endocrinology

Volumn 147, Issue 11, 2006, Pages 5249-5258

  Urs, Aarti N ^a   Dammer, Eric ^a   Sewer, Marion B ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CYCLIC AMP; CYTOCHROME P450 17; MESSENGER RNA; SPHINGOSINE; SPHINGOSYLPHOSPHORYLCHOLINE; STEROID RECEPTOR COACTIVATOR 1; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE ACTIVITY; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY;

BINDING SITES; BINDING, COMPETITIVE; CELLS, CULTURED; CYCLIC AMP; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; PHOSPHORYLCHOLINE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SPHINGOSINE; STEROID 17-ALPHA-HYDROXYLASE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33751250805     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0355     Document Type: Article

References (54)

1. Bakke M, Zhao L, Hanley NA, Parker KL 2001 SF-1: a critical mediator of steroidogenesis. Mol Cell Endocrinol 171:5-7
2. Sewer MB, Waterman MR 2003 ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc Res Tech 61:300-307
3. Hammer GD, Parker KL, Schimmer BP 2005 Minireview: transcriptional regulation of adrenocortical development. Endocrinology 146:1018-1024
4. Parker KL, Rice DA, Lala DS, Ikeda Y, Luo X, Wong M, Bakke M, Zhao L, Frigeri C, Hanley NA, Stallings N, Schimmer BP 2002 Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res 57:19-36
5. Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490
6. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen W, Nachtigal MW, Abbud R, Nilson JH, Parker KL 1994 The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8:2302-2312
7. Ozbay T, Merrill Jr AH, Sewer MB 2004 ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. Endocr Res 30:787-794
8. Ozbay T, Rowan A, Leon A, Patel P, Sewer MB 2006 Cyclic adenosine 5′-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1. Endocrinology 147:1427-1437
9. Sewer MB, Nguyen V, Huang C-J, Tucker PW, Kagawa N, Waterman MR 2002 Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation between p54nrb/NonO, PSF and SF-1, a complex which also participates in repression of transcription. Endocrinology 143:1280-1290
10. Rodriguez H, Hum DW, Staels B, Miller WL 1997 Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. J Clin Endocrinol Metab 82:365-371
11. Bakke M, Lund J 1995 Transcriptional regulation of the bovine CYP17 gene: two nuclear orphan receptors determine activity of cAMP-responsive sequence 2. Endocr Res 21:509-516
12. Desclozeaux M KI, Horn F, Fletterick RJ, Ingraham HA, 2002 Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol Cell Biol 22:7193-7203
13. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzuniene D, Bynum JM, Madauss K, Montana V, Lebedeva L, Suzawa M, Williams JD, Williams SP, Guy RK, Thornton JW, Fletterick RJ, Willson TM, Ingraham HA 2005 Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343-355
14. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, Xu HE 2005 Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17:491-502
15. Wang W, Zhang C, Marimuthu A, Krupka HI, Tabrizizad M, Shelloe R, Mehra U, Eng K, Nguyen H, Settachatgul C, Powell B, Milburn MV, West BL 2005 The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci USA 102:7505-7510
16. Rainey WE, Bird IM, Mason JI 1994 the NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol 99:R17-R20
17. Staels B, Hum DW, Miller WL 1993 Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Mol Endocrinol 7:423-433
18. Sullards MC, Merrill Jr AH 2001 Analysis of sphingosine-1-phosphate, ceramides, and other bioactive sphingolipids by liquid chromatography-tandem mass spectrometry. Sci STKE 67:PL1
19. Sullards MC 2000 Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. Methods Enzymol 312:32-45
20. Nikolova-Karakashian MN, Merrill Jr AH 1999 Ceramidases. In: Merrill Jr AH, Hannun YA, eds. Methods in enzymology. Pasadena, CA: Academic Press; 194-201
21. Nikolova-Karakashian MN, Merrill Jr AH 2000 Ceramidases. Methods Enzymol 311:194-201
22. Nichols JS, Parks DJ, Consler TG, Blanchard SG 1998 Development of a scintillation proximity assay for peroxisome proliferator-activated receptor γ ligand binding domain. Anal Biochem 257:112-119
23. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NCO, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT 2000 The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14:27-39
24. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, Mangelsdorf DJ 1999 Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc Natl Acad Sci USA 96:266-271
25. Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K 2000 Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485:63-99
26. Pettus BJ, Chalfant CE, Hannun YA 2002 Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585:114-125
27. Cuvillier O 2002 Sphingosine in apoptosis signaling. Biochim Biophys Acta 1585:153-162
28. Handschin C, Meyer UA 2005 Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 433:387-396
29. Gronemeyer H, Gustafsson JA, Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3:950-964
30. Gurnell M, Chatterjee VK 2004 Nuclear receptors in disease: thyroid receptor β, peroxisome-proliferator-activated receptor γ and orphan receptors. Essays Biochem 40:169-189
31. McEwan IJ 2004 Sex, drugs and gene expression: signalling by members of the nuclear receptor superfamily. Essays Biochem 40:1-10
32. Rother J, van Echten G, Schwarzmann G, Sandhoff K 1992 Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem Biophys Res Commun 189:14-20
33. Wang E, Norred WP, Bacon CW, Riley RT, Merrill Jr AH 1991 Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniforme. J Biol Chem 266:14486-14490
34. Mao C, Xu R, Bielawska A, Obeid LM 2000 Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity. J Biol Chem 275:6876-6884
35. El Bawab S, Birbes H, Roddy P, Szulc ZM, Bielawska A, Hannun YA 2001 Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. J Biol Chem 276:16758-16766
36. Okino N, Tani M, Imayama S, Ito M 1998 Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem 273:14368-14373
37. El Bawab S, Bielawska A, Hannun YA 1999 Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain. J Biol Chem 274:27948-27955
38. Seufferlein T, Rozengurt E 1995 Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway. J Biol Chem 270:24343-24351
39. Seufferlein T, Rozengurt E 1995 Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein. J Biol Chem 270:24334-24342
40. Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M 1998 Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 110:253-258
41. Desai NN, Spiegel S 1991 Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines. Biochem Biophys Res Commun 181:361-366
42. Desai NN, Carlson RO, Mattie ME, Olivera A, Buckley NE, Seki T, Brooker G, Spiegel S 1993 Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J Cell Biol 121:1385-1395
43. Chin TY, Chueh SH 1998 Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway. Am J Physiol 275:C1255-C1263
44. Yamada T, Okajima F, Ohwada S, Kondo Y 1997 Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions. Cell Mol Life Sci 53:435-441
45. Xu Y, Fang XJ, Casey G, Mills GB 1995 Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309:933-940
46. Xu Y, Casey G, Mills GB 1995 Effect of lysophospholipids on signaling in the human Jurkat T cell line. J Cell Physiol 163:441-450
47. Boguslawski G, Lyons D, Harvey KA, Kovala AT, English D 2000 Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem Biophys Res Commun 272:603-609
48. Sun L, Xu L, Henry FA, Spiegel S, Nielsen TB 1996 A new wound healing agent - sphingosylphosphorylcholine. J Invest Dermatol 106:232-237
49. Meyer zu Heringdorf D, Himmel HM, Jakobs KH 2002 Sphingosylphophorylcholine - biological functions and mechanisms of actions. Biochim Biophys Acta 1582:178-189
50. Kostenis E 2004 Novel clusters of receptors for sphingosine-1-phosphate, sphingophosyphorylcholine, and (lyso)-phosphatidic acid: New receptors for "old" ligands. J Cell Biochem 92:923-936
51. Xu Y, Zhu K, Hong G, Wu W, Baudhuin LM, Xiao Y, Damron DS 2000 Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol 2:261-267
52. Ludwig M-G, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, Seuwen K 2003 Proton-sensing G-protein-coupled receptors. Nature 425:93-98
53. Mogi C, Tomura H, Tobo M, Wang J-Q, Damirin A, Kon J, Komachi M, Hashimoto K, Sato K, Okajima F 2005 Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. J Pharmacol Sci 99:160-167
54. Bitar KN, Yamada H 1995 Modulation of smooth muscle contraction by sphingosylphosphorylcholine. Am J Physiol 269:G370-G377